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We have localized the D108 thermosensitive (cts) repressor gene to a region of DNA approx. 600 base pairs 
(bp) in length by sub-cloning an R.raI restriction endonuclease fragment (bp 200 to bp 802 from the left-end 
of the D108 genome). We determined that the gene product from this fragment appears to be the same 
size (19 kDa) as that expressed from clones containing larger fragments of D108 DNA. Results from in 
vitro gel electrophoresis band-retardation and in vivo immunity assays show that the sub-cloned repressor 
appears to be fully functional. 
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1. INTRODUCTION 
D108 and Mu are temperate Escherichia coli 
phages [1,2] that are unusual in that their linear, 37 
kilobase pair (kb) genomes also behave as giant, 
double-stranded DNA transposable elements. 
Although D108 and Mu share extensive homology 
(> 90070) at the DNA [3] and protein [4] levels, they 
are not homologous in their left-end regulatory 
regions [3]. This region of non-homology encodes 
the repressor (c), ner (a X cro-like protein [5,6]), 
and the amino-terminus of the transposase (A) 
gene product [7]. It has been previously reported 
(deduced from the DNA sequence) that the D108 
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The nucleotide sequence presented here has been submit- 
ted to the EMBL/GenBank database under the accession 
number YOO690 
repressor is a polypeptide of 174 amino acids, 
similar in size and amino acid composition to the 
Mu repressor protein [7,8]. We report here, 
however, that the D108 repressor protein has an 
apparent molecular mass (19 kDa) lower than that 
of Mu repressor protein (22.5 kDa) on SDS- 
polyacrylamide gels. Functional assays, both in 
vitro and in vivo, reveal that the sub-cloned 
repressor gene product appears to be fully active. 
2. MATERIALS AND METHODS 
Bacterial strains and plasmids used in this work 
are listed in table 1. D108 lysates (from strain 
LF4028) were prepared according to DuBow and 
Bukhari [4]. Plasmids used in this study were con- 
structed as follows (fig.1). Plasmid pUD78, con- 
taining 1500 bp of the left-end of D108, was 
constructed by ligating (with T4 DNA ligase, 
Pharmacia-PL Biochemicals, Milwaukee, WI), a 
3 130 bp EcoRI (Boehringer Mannheim, Canada) 
fragment from pSZ5326 (a pSClOl::mini-D108 
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Table 1 
Bacterial strains and plasmids 
September 1987 
Characteristics Origin 
Strain 
JM103 
LF120 
LF121 
LF2210 
LF2211 
LF4028 
Plasmid 
pDLlO8 
pDL109 
pUD68 
pUD78 
pop9515 
pOP95-15K AmpR, TetR, KanR, lac UV5 p/o containing vector 
Apro-lac, rps L, thi-1, hsd R- M+, sup E44, end E, sbc B /F’ 
tra D 36, pro AB, lacIq Z A Ml5 
JM 103 containing pUD68 
JM103 containing pOP95-15 
JM103 containing pDL108 
JM103 containing pDL109 
Apro-lac, trp 8am, rps L, /F’ pro-lacI::D108 ctsl0 
AmpR, TetR, D108 ctsl0 repressor expressed from the lac UV5 
promotor of pOP95-15 
AmpR, TetR, D108 ctsl0 repressor expressed from the lac UV5 
promotor of pOP95-15K 
AmpR, TetR, Mu cts62 repressor expressed from the lac UV5 
promotor of pOP95-15 
AmpR, TetR, D108 ctsl0 immunity region (c, ner, A ‘) 
AmpR, TetR, lac UV5 promoter/operator (p/o) containing 
vector 
[51 
this work 
this work 
this work 
this work 
I91 
this work 
this work 
this work 
this work 
I101 
I51 
pMD68 1 AmpR, Tep, Mini-Mu cts62 Lalumitre and 
DuBow 
(in preparation) 
plasmid [9]) into the EcoRI site of the fat UVS ex- 
pression vector pOP95-15 [lo]. A 900 bp DraI- 
PvuII fragment from pUD78 was purified by the 
‘crush and soak’ mehod [ 111. After EcoRI linker 
addition [12], the fragment was ligated to EcoRI- 
linearized pOP95-15, resulting in plasmid pDL108. 
A 600 bp RsaI (BMC) fragment (bp 200 to bp 802 
from the left-end of the D108 phage genome [7]) 
was isolated from pDL108 and ligated into the 
SmaI site of pOP95-15K [5], resulting in plasmid 
pDL109. To clone the Mu cts62 repressor gene, the 
left-most 1 kb of Mu DNA was isolated from 
plasmid pMD681 (Lalumiere and DuBow, in 
preparation) as an EcoRI fragment and ligated in- 
to EcoRI-linearized pOP95-15, resulting in 
plasmid pUD68 (see table 1). E. coli strain JM103 
(table 1) was transformed [13] and colonies con- 
taining the recombinant plasmids were isolated on 
LB plates [14] containing 40 pg/ml ampicillin. 
Plasmid-encoded gene products were labelled in 
vivo with [35S]methionine (1120 Ci/mmol, Amer- 
sham) by the chloramphenicol release procedure of 
200 
Neidhardt et al. [ 151 and visualized by 
fluorography [16] after electrophoresis on 16% 
SDS-polyacrylamide gels [17]. Crude protein ex- 
tracts and band-retardation assays were prepared 
and conducted as described by Tolias and DuBow 
[5]. Relative immunity to D108 superinfection was 
tested by applying serial dilutions [ 10z-10’ D108 
plaque-forming units (PFU)/ml] prepared in Mu 
buffer [4] to bacterial awns in 0.75% soft agar, on 
LB agar plates containing 2.5 mM CaClz and 
2.5 mM MgS04 [14], and 1 mM isopropyl-,&D- 
pyranoside (IPTG) to induce plasmid-encoded 
gene expression. The plates were incubated over- 
night at either 32 or 43°C and the presence or 
absence of bacterial lysis (plaque formation) was 
noted. 
3. RESULTS 
Fig.2 displays the proteins expressed from 
plasmids pDL108 and pDL109 (fig.1) labelled in 
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Fig. 1. Construction of recombinant plasmids: (A) the D108 ctsl0 repressor gene, cloned with a DraI restriction fragment 
containing the left-most 865 bp of the D108 genome, (B) the D108 ctsl0 repressor gene, cloned as a 600 bp RsaI 
restriction fragment (bp 200-802 from the left-end of the D108 genome), and (C) the Mu cts.62 repressor gene, cloned 
with an EcoRI restriction fragment containing the left-most 1000 bp of the Mu genome, all under the control of the 
Zac UV5 promotor in 
Fig.2. Autoradiogram of [35S]methionine-labelled 
proteins expressed from (A) LF121 (containing the 
vector, pOP95-15), (B) LF120 (containing the Mu cts62 
repressor gene), (C) LF2210 (containing the D108 ctsl0 
repressor gene cloned from the DraI site), and (D) 
LF2211 (containing the D108 ctsl0 repressor gene cloned 
on the 600 bp &a1 fragment). (M) r4C-labelled marker 
proteins (BRL): 68.0 kDa, bovine serum albumin; 
43.0 kDa, ovalbumin; 18.4 kDa, cz-chymotrypsinogen; 
Fig.3A and C displays the retarded migration of 
a 32P-labelled restriction fragment (473 bp, 
Sau%-BgnI) containing the D108 immuni- 
ty/operator region [7] by increasing amounts of 
crude protein extract containing the D108 ds 
repressor derived from either LF2210 (pDL108) or 
LF2211 (pDL109). Fig.3B and D demonstrates 
that these extracts do not affect the migration of a 
385 bp HinfI-EcoRI control fragment derived 
from DlO8 sequences adjacent to and downstream 
of the D108 immunity/operator region [7]. 
14.3 kDa, fl-lactoglobin. Cells containing pDL108 (LF2210) and pDL109 
pOP95-15 [lo]. 
vivo with [3’S]methionine [14]. Lane A of fig.2 
shows the proteins expressed in the vector- 
containing (pOP95-15) strain LF121, while lane B 
shows the proteins expressed from the Mu 
repressor plasmid pUD68. A polypeptide with an 
apparent molecular mass of 22.5 kDa found in 
lane B, but not in lane A, most likely represents the 
174 amino acid Mu cts repressor gene product 
[18,19]. Both lanes C (pDL108) and D (pDL109) 
contain strongly expressed polypeptides with an 
apparent molecular mass of 19 kDa that are not 
represented in lanes A and B, which suggests that 
the 19 kDa proteins are the cloned D108 cts 
repressor gene products. 
201 
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Fig.3. Band-retardation assays with D108 cts repressor-containing crude protein extracts. 2-10 ng “P-1abelled DNA 
restriction fragment with (A,C) or without (B,D) the D108 repressor binding site were mixed with l-5 cg unlabelled, 
sonicated calf thynius (non-specific) competitor DNA and increasing amounts of crude protein extract made from either 
LF2210 or LF2211. (A) Crude protein extract of LF2210 with the 473 bp Sau96-BglII restriction fragment containing 
the D108 immunity/operator region (specific substrate); (B) crude protein extracts of LF2210 with the 385 bp HinfI- 
EcoRI restriction fragment (non-specific substrate); (C) crude protein extract of LF2211 with the 473 bp (specific) 
restriction fragment; (D) crude protein extract of LF2211 with the 385 bp (non-specific) restriction fragment. The 
amount of crude protein extract added in each reaction mixture was: (b) 0.05 pg (1.4 pg/ml), (c) 0.10 yg (2.8 ,ug/ml), 
(d) 0.50 yg (14.0 ag/ml), (e) 1.0 pg (28.0 pg/ml), and (f) 5.0 pg (140.0 rg/ml). (a) 32P-labelled DNA fragment incubated 
without crude protein extract. 
(LF2211) were immune to superinfection by D108 
phage at 32°C but not at 43”C, while the vector- 
containing control strain (LF121) was not immune 
at either temperature (table 2). 
Table 2 
Comparative immunity test 
Strain Tempera- Phage 
ture 
PFU/ml 
ld lo3 lo4 lo5 lo6 10’ 
LF2210 32’C D108 - - - - - + 
43°C D108 .* * * * + + 
LF2211 32°C D108 - - - - - + 
43°C D108 * * * * + + 
LF121 32°C D108 + + + + + + 
43°C D108 + + + + + + 
+, clearly discernible plaque; *, a poorly defined but 
detectable turbid zone of lysis; - , no detectable zone of 
lysis 
202 
4. DISCUSSION 
We have localized a functional D108 repressor 
gene to a region of DNA approx. 600 bp in length. 
Mizuuchi et al. [7] proposed (from the DNA se- 
quence) that the open reading frame of the DlO8 
repressor gene begins at bp 864 from the D108 left- 
end to encode a Mu-sized repressor protein. 
However, functional assays both in vitro (band- 
retardation assays) and in vivo (immunity to 
superinfection) show that sequences located be- 
tween bp 200 and 802 from the left-end of the 
D108 genome most probably encode ‘the DlO8 
repressor. Examination of the nucleotide sequence 
of this region [7] reveals a GTG codon at position 
768 bp (from the D108 left-end), in the same 
reading frame as the putative 174 amino acid D108 
repressor, which could serve as the initiation codon 
of the smaller repressor protein. This protein 
would consist of 142 amino acids and appears to 
migrate on SDS-polyacrylamide gels more slowly 
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(19 kDa) than its amino acid sequence wouid 
predict (15.8 kDa), as does the Mu repressor pro- 
tein (22-26 kDa vs 19 kDa) [8]. The initiation 
codon of the luc repressor is also GTG [20] and this 
protein also migrates on SDS-polyacrylamide gels 
more slowly (40-50 kDa) than would be predicted 
from its amino acid sequence (38 kDa) [20,21]. 
The 142 amino acid D108 repressor retains its 
homology with the amino-terminus of the D108 A 
protein [7], and contains a b&-helical structure 
(amino acid residues 7-27 of the putative 142 
amino acid D108 repressor) observed in many 
DNA-binding proteins [22] within which is found 
the putative D108 thermosensitive mutation [7]. It 
is possible that the 174 amino acid polypeptide 
predicted by Mizuuchi et al. [7] can be expressed 
from a DlOS prophage, but may perform a dif- 
ferent role from that of the smaller (142 amino 
acid) D108 repressor protein, as is the case for Tn5 
protein 1 and its internally initiated, in-frame pro- 
tein 2 [23,24]. The difference in the size of the 
D108 and Mu repressor proteins suggests that they 
may be biochemically different and perform dif- 
ferent roles in the regulation of D108 and Mu 
transposition. The nature of these differences is 
currently under investigation. 
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